101 Patents
- 0 cites
- 0 cites
- US125900822026Fused Tricyclic Derivative and Pharmaceutical Application Thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., Ltd.
0 cites - US125838412026Tetrahydropyrrolocyclic Compound and Application Thereof
Breakthrough Pharmaceuticals Inc.
0 cites - 0 cites
- US1257725320265,6-dihydrothieno[3,4-h]quinazoline Compound
SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT CO., Ltd.
0 cites - 0 cites
- 0 cites
- 0 cites
- US125654802026Thiophene Derivatives as Xanthine Oxidase Inhibitors and Application Thereof
Tonghua Dongbao Pharmaceutical Co., Ltd.
0 cites - US1256548120266,7-dimethoxy-3-(pyridin-2-yl)quinoline Compounds for Inhibiting RET
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory
0 cites - 0 cites
- 0 cites
- US125528122026Pyridone Multiple-membered Ring Derivatives and Use Thereof
PHAENO THERAPEUTICS CO., Ltd.
0 cites - US125528132026Heterocyclic Substituted Pyrimidopyran Compound and Use Thereof
MEDSHINE DISCOVERY Inc.
0 cites - 0 cites
- US125393352026Tricyclic Polypeptide Conjugated Drug and Use Thereof
CONJUSTAR (ZHUHAI) BIOLOGICS CO., Ltd.
0 cites - US125344772026Compound Having KHK Inhibitory Effect
HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL Co. , Ltd.
0 cites - US125094402025Fluorovinylbenzamide Compound as PD-L1 Immunomodulator
Novaonco JS Therapeutics Co., Ltd.
0 cites - US124974122025Compound as Highly Selective ROS1 Inhibitor and Use Thereof
GUANGZHOU JOYO PHARMATECH CO., Ltd.
0 cites - 0 cites
- 0 cites
- US124862662025Crystalline Form of JAK Inhibitor and Application Thereof
ZHUHAI UNITED LABORATORIES CO., Ltd.
0 cites - 0 cites
- 0 cites
- 0 cites
- US124798392025Crystalline Form of ATR Inhibitor and Use Thereof
Wuxi Biocity Biopharmaceutics Co., Ltd.
0 cites - US124732582025Crystal Form of Pyridinylphenyl Compound and Preparation Method Therefor
ZHUHAI UNITED LABORATORIES CO., Ltd.
0 cites - US124668162025Fused Cyclic Compound Capable of Degrading Protein and Use Thereof
MEDSHINE DISCOVERY Inc.
0 cites - 0 cites
- 0 cites
- US124599182025Isoquinolinone Derivatives Serving as Rock Protein Kinase Inhibitors and Use Thereof
GUANGZHOU OCUSUN OPTHALMIC BIOTECHNOLOGY CO., Ltd.
0 cites - US124599402025Oxazole Compound as Multi-targeted Inhibitor of IRAK4 and BTK
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
0 cites - US124483782025Fluoropyrrolopyridine Compound and Application Thereof
Wuxi Life Fountain Biotech Co., Ltd
0 cites - 0 cites
- 0 cites
- US124212362025Seven-membered Heterocyclic Derivative Acting as KRAS G12C Mutant Protein Inhibitor
Medshine Discovery Inc.
0 cites - 0 cites
- 0 cites
- US124101552025Salt Form and Crystal Form of Tetrahydrocyclohepta Indazole Compound
ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., Ltd.
0 cites - US124101962025Benzopyrimidine Compounds and Use Thereof0 cites
- US123981382025FGFR Inhibitor Compound in Solid Form and Preparation Method Therefor
CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., Ltd.
0 cites - US123981532025Spiro Compound Serving as ERK Inhibitor, and Application Thereof
D3 BIO (WUXI) CO., Ltd.
0 cites - US123782412025Pyridine Derivative as FGFR and VEGFR Dual Inhibitors
Cgenetech (Suzhou,china) CO., Ltd.
0 cites - US123782532025Pyrrolopyrimidine Compound as BTK Inhibitor and Use Thereof
ZHEJIANG LONGCHARM BIO-TECH PHARMA. CO., Ltd.
0 cites - US123782772025SGLTS/DPP4 Inhibitor and Application Thereof
DONGBAO PURPLE STAR (HANGZHOU) BIOPHARMACEUTICAL CO., Ltd.
0 cites - US123656862025Compound as Porcupine Inhibitor and Use Thereof
JIANGSU KANION PHARMACEUTICAL CO., Ltd.
0 cites - US123589272025IRAK4 Inhibitor Crystal and Preparation Method Therefor
Chia Tai Tianqing Pharmaceutical Group Co., Inc.
0 cites - US123515872025Bicyclic Compound as RIP-1 Kinase Inhibitor and Application Thereof
Medshine Discovery Inc.
0 cites - 0 cites
- 0 cites
- US1232569520255-(4-pyridyloxy)pyrazole Compounds Serving as Tgf-βr1 Kinase Inhibitor
JIANGSU AOSAIKANG PHARMACEUTICAL CO., Ltd.
0 cites - US123257032025Fused Ring Compound as FGFR and VEGFR Dual Inhibitor
Cgenetech (Suzhou, China) CO., Ltd.
0 cites - 0 cites
- US123109482025Application of Monocyclic Β-lactam Compound in Pharmacy
SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY CO., Ltd
0 cites - US123123472025Azaindole Derivative and Use Thereof as FGFR and C-met Inhibitor
WUXI LIFE FOUNTAIN BIOTECH CO., Ltd
0 cites - US122971972025Pyrazolopyridine Compound as RET Inhibitor and Application Thereof
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., Ltd. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY
0 cites - US122915362025Crystal Form of Wee1 Inhibitor Compound and Use Thereof
Wuxi Biocity Biopharmaceutics Co., Ltd.
0 cites - US122583672025Glucoside Derivative That Acts as SGLT1 Inhibitor and Application Thereof
MEDSHINE DISCOVERY Inc.
0 cites - US122408492025Nitrogen-containing Spiro Derivative as RET Inhibitor
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., Ltd. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY
0 cites - 0 cites
- US121801842024Pyrimidopyrazolone Derivative as Wee1 Inhibitor and Use Thereof
Wuxi Biocity Biopharmaceutics Co., Ltd.
0 cites - 0 cites
- US121520132024Vinylpyridine Carboxamide Compound as PD-L1 Immunomodulator
Novaonco JS Therapeutics Co., Ltd.
0 cites - US121227802024Pyrimidinyl Group-containing Tricyclic Compound Serving as C-met Inhibitor
JIANGSU AOSAIKANG PHARMACEUTICAL CO., Ltd.
0 cites - US121163672024Ring-modified Proline Short Peptide Compound and Use Thereof
FUJIAN AKEYLINK BIOTECHNOLOGY CO., Ltd.
0 cites - US120775132024Process Route of Compound of Formula (IV), Crystal Form and Preparation Method Therefor
SHANDONG DANHONG PHARMACEUTICAL CO., Ltd.
0 cites - 0 cites
- 0 cites
- US120308972024Pyrrolo[2,1-f][1,2,4]triazine Derivatives Serving as Selective HER2 Inhibitors and Application Thereof
MEDSHINE DISCOVERY Inc.
0 cites - US120244942024Salt of LSD1 Inhibitor and a Polymorph Thereof
CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., Ltd.
0 cites - US120180272024Macrocyclic Derivatives Acting as Xia Factor Inhibitor
China Resources Biopharmaceutical Company Limited
0 cites - 0 cites
- US119935962024Fused Tri-cyclic Compound as PDE3/PDE4 Dual Inhibitor
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., Ltd.
0 cites - 0 cites
- US119326522024Pyrrolidinyl Urea Derivatives and Application Thereof in Trka-related Diseases
ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., Ltd.
0 cites - US119198962024[1,2,4]triazolo[1,5-a]pyridine Compound as JAK Inhibitor and Use Thereof
ZHUHAI UNITED LABORATORIES CO., Ltd.
0 cites - 0 cites
- US1189139820242,3-dihydro-1h-pyrrolizine-7-formamide Derivative and Application Thereof
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., Ltd.
0 cites - US118664332024Diarylthiohydantoin Compound as Androgen Receptor Antagonist
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., Ltd.
0 cites - 0 cites
- US117607512023Benzo 2-azaspiro[4.4]nonane Compound and Use Thereof
HELIOEAST SCIENCE & TECHNOLOGY CO., Ltd.
0 cites - US117533772023Crystal Form of 2-methyl-2-propanol and Amino-substituted Aryl Compound
ZHUHAI UNITED LABORATORIES CO., Ltd.
0 cites - US117390902023Substituted Pyrazlo[3,4-c]pyridines as Selective BTK Kinase Inhibitors
JUMBO DRUG BANK CO., Ltd.
0 cites - 0 cites
- 0 cites
- US117024002023Salt Types, Crystal Forms, and Preparation Methods for Benzopyrazole Compounds as RHO Kinase Inhibitors
MEDSHINE DISCOVERY Inc.
0 cites - US1169197420233,9-diazaspiro[5,5]undecane Compound as FLT3 and AXL Inhibitors
MEDSHINE DISCOVERY Inc.
0 cites - US116800612023Crystal Forms C and E of Pyrazin-2(1h)-one Compound and Preparation Method Therefor
ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., Ltd.
0 cites - US116800702023Thieno[2,3-c]pyridazin-4(1h)-one Derivative and Application Thereof
MEDSHINE DISCOVERY Inc.
0 cites - 0 cites
- US116552482023Pyridone-pyrimidine Derivative Acting as KRAS G12C Mutein Inhibitor
MEDSHINE DISCOVERY Inc.
0 cites - US116492452023Cyclopropylamine Compound as LSD1 Inhibitor and Use Thereof
Helioeast Science & Technology Co., Ltd.
0 cites - 0 cites
- 0 cites
- 0 cites
- US116135452023Macrocyclic Compound Serving as Wee1 Inhibitor and Applications Thereof
WUXI BIOCITY BIOPHARMACEUTICS CO., Ltd.
0 cites - US116033662023Crystalline Form and B Crystalline Form of Pyrazine-2(1h)-ketone Compound and Preparation Method Thereof
ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., Ltd.
0 cites - US115977222023Crystal Form D of Pyrazine-2(1h)-ketone Compound and Preparation Method Therefor
ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., Ltd.
0 cites - 0 cites
- US115422722023Five-membered Heteroaryl-fused Imidazole Compound and Application Thereof
Hangzhou Sciwind Biosciences Co., Ltd
0 cites